- $27.01m
- $152.93m
- CNY12.56bn
Brief: 111 Inc Announces Q4 2020 Financial Results
U.S. STOCKS ON THE MOVE-CHF Solutions, Plug Power, NRG Energy
111 Inc: Gains on BeiGene tie-up to create oncology management platform
Brief: 111 Inc Enters Into First-Ever Strategic Partnership With Beigene
Brief: 111 Inc Signs Strategic Cooperation Agreement With Jilin Baiyi Doctor Group To Create And Deliver New Models For Internet Medical Services
Brief: 111, Inc Reports Q3 2020 Non-Gaap Loss Per ADS Was RMB1.15
Brief: 111 Inc Says Entered Strategic Partnership With Bayer Healthcare To Collaborate On Drug Commercialization Initiatives In China
Brief: 111, Inc. Teams Up With Huluwa Pharmaceutical To Explore The New Domain Of "Internet + Pharmaceutical"
Brief: 111 To Be The Omni-Channel Drug Commercialization Partner Of Xiangxu Pharmaceutical For Traditional Chinese Medicine
Brief: 111, Inc. And Shanghai Uniondrug Information Technology Join Hands To Advance Innovation In Commercial Insurance Payment
Brief: 111 Inc Partners With Baiyunshan Pharmaceutical Sales In Digital Medicine Innovation
Brief: 111 Inc Reports Qtrly Net Revenues Of RMB 1.62 Bln
Brief: 111, Inc Announces Strategic Plan To Expand Access To China's Capital Markets
Brief: 111 Inc Launches Lung Cancer Patient Care Program For Full Life-Cycle Management Of Tumor
Brief: 111 Launched The Overseas Direct Delivery Service
Brief: 111 And Wenjiang People's Hospital To Build Online Cancer Diagnosis And Treatment Platform
Brief: 111 Launches Free Consultation Services For Chinese Citizens Abroad Against COVID-19
Brief: 111 Sees Q1 Revenue Up About 113.5% To 125.7%
Brief: 111 Inc Announced Strategic Partnership With Winhealth Pharma Group